FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135536758> ?p ?o ?g. }

• W3135536758 abstract "Abstract Background An abrupt increase of thyroid cancer has been witnessed paralleling the supplemented iodine intake in formerly iodine-deficient countries. And increased iodine intake has been linked to the rising incidence rate of papillary thyroid cancer (PTC). However, the correlation between iodine and clinicopathological features of PTC has not been well-characterized. This study aimed to investigate the associations between iodine intake and the clinicopathological features of PTC patients. Methods Three hundred and fifty-nine PTC patients who received surgical treatment in Peking Union Medical College Hospital from May 2015 to November 2020 were retrospectively reviewed. The associations between urinary iodine (UI), urinary iodine/creatinine ratio (UI/U-Cr), and the clinicopathological features of PTC were analyzed. Univariate and multivariate analysis were performed to investigate the relationship between UI level and central lymph node metastasis (CLNM). Results There were no significant differences in UI in different groups according to the variables studied, except that patients with CLNM had higher UI level than CLNM(−) patients. No associations were found between UI/U-Cr and clinicopathological features except variant subtypes (classic/follicular). After dividing patients into high-iodine group and low-iodine group, more patients were found to have CLNM in the high-iodine group (p = 0.02). In addition, younger age, larger tumor size, and classic variant were positively correlated with CLNM (p < 0.05). Univariate analysis showed that insufficient iodine intake (≤ 99 μg/L) was associated with decreased CLNM risk in PTC. And after defining insufficient iodine intake as ≤ 109 μg/L and above requirements as ≥ 190 μg/L, multivariate analysis showed that lower iodine was associated with CLNM in total population of PTC (OR 0.53, 95% CI 0.31–0.91) and in PTC < 1 cm (papillary thyroid microcarcinoma, PTMC) (OR 0.43, 95% CI 0.21–0.87). Conclusions Low iodine was a protective factor for CLNM in papillary thyroid cancer, particularly in those < 1 cm. These results indicated that iodine may not only be an initiator of tumorigenesis, but also a promoter of the development of PTC." @default.
• W3135536758 created "2021-03-15" @default.
• W3135536758 creator A5049279706 @default.
• W3135536758 creator A5051885991 @default.
• W3135536758 creator A5058479146 @default.
• W3135536758 creator A5065190578 @default.
• W3135536758 creator A5068218262 @default.
• W3135536758 creator A5073364186 @default.
• W3135536758 creator A5075420772 @default.
• W3135536758 creator A5085280722 @default.
• W3135536758 creator A5086487768 @default.
• W3135536758 creator A5087210747 @default.
• W3135536758 date "2021-07-12" @default.
• W3135536758 modified "2023-10-18" @default.
• W3135536758 title "Low urinary iodine is a protective factor of central lymph node metastasis in papillary thyroid cancer: a cross-sectional study" @default.
• W3135536758 cites W1491499229 @default.
• W3135536758 cites W1967231417 @default.
• W3135536758 cites W1967511948 @default.
• W3135536758 cites W1977694358 @default.
• W3135536758 cites W1983353299 @default.
• W3135536758 cites W2025340199 @default.
• W3135536758 cites W2033941366 @default.
• W3135536758 cites W2051034864 @default.
• W3135536758 cites W2069368477 @default.
• W3135536758 cites W2069805333 @default.
• W3135536758 cites W2076897322 @default.
• W3135536758 cites W2089602144 @default.
• W3135536758 cites W2090528537 @default.
• W3135536758 cites W2115684001 @default.
• W3135536758 cites W2125422131 @default.
• W3135536758 cites W2146369896 @default.
• W3135536758 cites W2158651948 @default.
• W3135536758 cites W2200091542 @default.
• W3135536758 cites W2532042917 @default.
• W3135536758 cites W2602437944 @default.
• W3135536758 cites W2763277954 @default.
• W3135536758 cites W2770866301 @default.
• W3135536758 cites W2892738396 @default.
• W3135536758 cites W2897488152 @default.
• W3135536758 cites W2911558192 @default.
• W3135536758 cites W3004353613 @default.
• W3135536758 cites W3017786087 @default.
• W3135536758 cites W3024796810 @default.
• W3135536758 cites W3026900255 @default.
• W3135536758 cites W3094820062 @default.
• W3135536758 cites W4298152758 @default.
• W3135536758 cites W940609712 @default.
• W3135536758 doi "https://doi.org/10.1186/s12957-021-02302-6" @default.
• W3135536758 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8276512" @default.
• W3135536758 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34253203" @default.
• W3135536758 hasPublicationYear "2021" @default.
• W3135536758 type Work @default.
• W3135536758 sameAs 3135536758 @default.
• W3135536758 citedByCount "5" @default.
• W3135536758 countsByYear W31355367582022 @default.
• W3135536758 countsByYear W31355367582023 @default.
• W3135536758 crossrefType "journal-article" @default.
• W3135536758 hasAuthorship W3135536758A5049279706 @default.
• W3135536758 hasAuthorship W3135536758A5051885991 @default.
• W3135536758 hasAuthorship W3135536758A5058479146 @default.
• W3135536758 hasAuthorship W3135536758A5065190578 @default.
• W3135536758 hasAuthorship W3135536758A5068218262 @default.
• W3135536758 hasAuthorship W3135536758A5073364186 @default.
• W3135536758 hasAuthorship W3135536758A5075420772 @default.
• W3135536758 hasAuthorship W3135536758A5085280722 @default.
• W3135536758 hasAuthorship W3135536758A5086487768 @default.
• W3135536758 hasAuthorship W3135536758A5087210747 @default.
• W3135536758 hasBestOaLocation W31355367581 @default.
• W3135536758 hasConcept C126322002 @default.
• W3135536758 hasConcept C142052008 @default.
• W3135536758 hasConcept C142724271 @default.
• W3135536758 hasConcept C143998085 @default.
• W3135536758 hasConcept C144301174 @default.
• W3135536758 hasConcept C191897082 @default.
• W3135536758 hasConcept C192562407 @default.
• W3135536758 hasConcept C2779761222 @default.
• W3135536758 hasConcept C2780140570 @default.
• W3135536758 hasConcept C2780849966 @default.
• W3135536758 hasConcept C2781461381 @default.
• W3135536758 hasConcept C38180746 @default.
• W3135536758 hasConcept C526584372 @default.
• W3135536758 hasConcept C539932907 @default.
• W3135536758 hasConcept C71924100 @default.
• W3135536758 hasConceptScore W3135536758C126322002 @default.
• W3135536758 hasConceptScore W3135536758C142052008 @default.
• W3135536758 hasConceptScore W3135536758C142724271 @default.
• W3135536758 hasConceptScore W3135536758C143998085 @default.
• W3135536758 hasConceptScore W3135536758C144301174 @default.
• W3135536758 hasConceptScore W3135536758C191897082 @default.
• W3135536758 hasConceptScore W3135536758C192562407 @default.
• W3135536758 hasConceptScore W3135536758C2779761222 @default.
• W3135536758 hasConceptScore W3135536758C2780140570 @default.
• W3135536758 hasConceptScore W3135536758C2780849966 @default.
• W3135536758 hasConceptScore W3135536758C2781461381 @default.
• W3135536758 hasConceptScore W3135536758C38180746 @default.
• W3135536758 hasConceptScore W3135536758C526584372 @default.
• W3135536758 hasConceptScore W3135536758C539932907 @default.
• W3135536758 hasConceptScore W3135536758C71924100 @default.
• W3135536758 hasIssue "1" @default.
• W3135536758 hasLocation W31355367581 @default.

• next